MYCN and neoplasm: Using a published single-cell RNA-seq (scRNA-seq) dataset of tumor cells from high-risk lesions lacking MYCN amplification (Dong et al., 2020), we inferred cell cycle status based on expression of cell cycle-associated genes and then assessed expression of numerous neuronal markers.